Provided by Tiger Fintech (Singapore) Pte. Ltd.

Maze Therapeutics

32.91
-0.3100-0.93%
Post-market: 32.910.00000.00%17:32 EDT
Volume:176.92K
Turnover:5.84M
Market Cap:1.57B
PE:-8.63
High:33.91
Open:33.51
Low:32.33
Close:33.22
52wk High:34.29
52wk Low:6.71
Shares:47.85M
Float Shares:20.43M
Volume Ratio:0.63
T/O Rate:0.87%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.8154
EPS(LYR):1.42
ROE:-62.95%
ROA:-30.29%
PB:6.01
PE(LYR):23.16

Loading ...

Company Profile

Company Name:
Maze Therapeutics
Exchange:
NASDAQ
Establishment Date:
2017
Employees:
125
Office Location:
171 Oyster Point Blvd,Suite 300,South San Francisco,California,United States
Zip Code:
94080
Fax:
- -
Introduction:
- -

Directors

Name
Position
Hervé Hoppenot
Director and Chairman of the Board
Jason Coloma
Chief Executive Officer and Director
Catherine Angell Sohn
Director
Charles Homcy
Director
Daniel Spiegelman
Director
Jonathan Lim
Director
Nancy C. Andrews
Director
Neil Exter
Director
Richard Scheller
Director
Sekar Kathiresan
Director

Shareholders

Name
Position
Jason Coloma
Chief Executive Officer and Director
Misbah Tahir
Chief Financial Officer
Atul Dandekar
Chief Strategy and Business Officer
Courtney Phillips
General Counsel and Corporate Secretary
Harold S. Bernstein
President, Research and Development and Chief Medical Officer